The Role of MicroRNAs in Myocarditis—What Can We Learn from Clinical Trials?

Olga Grodzka, Grzegorz Procyk, Aleksandra Gąsecka

Research output: Contribution to journalReview articleAcademicpeer-review


Myocarditis is an inflammatory disease of the heart with a viral infection as the most common cause. It affects most commonly young adults. Although endomyocardial biopsy and cardiac magnetic resonance are used in the diagnosis, neither of them demonstrates all the required qualities. There is a clear need for a non-invasive, generally available diagnostic tool that will still remain highly specific and sensitive. These requirements could be possibly met by microribonucleic acids (miRNAs), which are small, non-coding RNA molecules that regulate many fundamental cell functions. They can be isolated from cells, tissues, or body fluids. Recently, several clinical studies have shown the deregulation of different miRNAs in myocarditis. The phase of the disease has also been evidenced to influence miRNA levels. These changes have been observed both in adult and pediatric patients. Some studies have revealed a correlation between the change in particular miRNA concentration and the degree of cardiac damage and inflammation. All of this indicates miRNAs as potential novel biomarkers in the diagnosis of myocarditis, as well as a prognostic tool for this condition. This review aims to summarize the current knowledge about the role of miRNAs in myocarditis based on the results of clinical studies.
Original languageEnglish
Article number16022
JournalInternational journal of molecular sciences
Issue number24
Publication statusPublished - 1 Dec 2022


  • cardiomyopathy
  • clinical trials
  • inflammation
  • microRNA
  • myocarditis

Cite this